FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093046114> ?p ?o ?g. }

• W2093046114 endingPage "213" @default.
• W2093046114 startingPage "204" @default.
• W2093046114 abstract "The risk factors for women developing breast and endometrial cancers are all associated with a lifetime of estrogen exposure. Estrogen replacement therapy in particular has been correlated with a slight increased cancer risk. Previously, we showed that equilenin, a minor component of Premarin (Wyeth-Ayerst), was metabolized to highly cytotoxic quinoids which caused oxidative stress and alkylation of DNA in vitro [Bolton, J. L., Pisha, E., Zhang, F., and Qiu, S. (1998) Chem. Res. Toxicol. 11, 1113−1127]. In this study, we have compared the chemistry of the major catechol metabolite of equilin (4-hydroxyequilin), which is found in several estrogen replacement formulations, to the equilenin catechol (4-hydroxyequilenin). Unlike endogenous catechol estrogens, both equilin and equilenin were primarily converted by rat liver microsomes to 4-hydroxylated rather than 2-hydroxylated o-quinone GSH conjugates. With equilin, a small amount of 2-hydroxyequilin GSH quinoids were detected (4-hydroxyequilin:2-hydroxyequilin ratio of 6:1); however, no peaks corresponding to 2-hydroxyequilenin were observed in incubations with equilenin. These data suggest that unsaturation in the B ring alters the regiochemistry of P450-catalyzed hydroxylation from primarily 2-hydroxylation for endogenous estrogens to 4-hydroxylation for equine estrogens. 4-Hydroxyequilenin-o-quinone reacts with GSH to give two mono-GSH conjugates and one di-adduct. The behavior of 4-hydroxyequilin was found to be more complex than 4-hydroxyequilenin as conjugates resulting from 4-hydroxyequilenin were detected in addition to the 4-hydroxyequilin−GSH adducts. The mechanism of decomposition of 4-hydroxyequilin likely involves isomerization to a quinone methide which readily aromatizes to 4-hydroxyequilenin followed by autoxidation to 4-hydroxyequilenin-o-quinone. Similar results were obtained with 2-hydroxyequilin, although, in contrast to 4-hydroxyequilenin, 2-hydroxyequilenin does not autoxidize and the reaction stops at the catechol. Since 4-hydroxyequilin is converted to 4-hydroxyequilenin and 4-hydroxyequilenin-o-quinone, similar effects were observed for this equine catechol, including consumption of NAD(P)H likely by the 4-hydroxyequilenin-o-quinone, depletion of molecular oxygen by 4-hydroxyequilenin or its semiquinone radical, and alkylation of deoxynucleosides and DNA by 4-hydroxyequilenin quinoids. Finally, preliminary studies conducted with the human breast tumor cell line MCF-7 demonstrated that the cytotoxic effects of the catechol estrogens from estrone, equilin, and 2-hydroxyequilenin were similar, whereas 4-hydroxyequilenin was a much more potent cytotoxin (∼30-fold). These results suggest that the catechol metabolites of equine estrogens have the ability to cause alkylation/redox damage in vivo primarily through formation of 4-hydroxyequilenin quinoids." @default.
• W2093046114 created "2016-06-24" @default.
• W2093046114 creator A5001452107 @default.
• W2093046114 creator A5026872517 @default.
• W2093046114 creator A5045867873 @default.
• W2093046114 creator A5055374370 @default.
• W2093046114 creator A5066272361 @default.
• W2093046114 creator A5080984608 @default.
• W2093046114 creator A5088160011 @default.
• W2093046114 date "1999-01-09" @default.
• W2093046114 modified "2023-09-23" @default.
• W2093046114 title "The Major Metabolite of Equilin, 4-Hydroxyequilin, Autoxidizes to an <i>o</i>-Quinone Which Isomerizes to the Potent Cytotoxin 4-Hydroxyequilenin-<i>o</i>-quinone" @default.
• W2093046114 cites W1538841780 @default.
• W2093046114 cites W154360866 @default.
• W2093046114 cites W2025911184 @default.
• W2093046114 cites W2026572579 @default.
• W2093046114 cites W2041258563 @default.
• W2093046114 cites W2046767468 @default.
• W2093046114 cites W2065725392 @default.
• W2093046114 cites W2073189025 @default.
• W2093046114 cites W2078584290 @default.
• W2093046114 cites W2100690704 @default.
• W2093046114 cites W2328091381 @default.
• W2093046114 cites W2607238143 @default.
• W2093046114 cites W3005480718 @default.
• W2093046114 doi "https://doi.org/10.1021/tx980217v" @default.
• W2093046114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10027800" @default.
• W2093046114 hasPublicationYear "1999" @default.
• W2093046114 type Work @default.
• W2093046114 sameAs 2093046114 @default.
• W2093046114 citedByCount "81" @default.
• W2093046114 countsByYear W20930461142012 @default.
• W2093046114 countsByYear W20930461142013 @default.
• W2093046114 countsByYear W20930461142014 @default.
• W2093046114 countsByYear W20930461142015 @default.
• W2093046114 countsByYear W20930461142016 @default.
• W2093046114 countsByYear W20930461142017 @default.
• W2093046114 countsByYear W20930461142018 @default.
• W2093046114 countsByYear W20930461142019 @default.
• W2093046114 countsByYear W20930461142020 @default.
• W2093046114 countsByYear W20930461142021 @default.
• W2093046114 countsByYear W20930461142022 @default.
• W2093046114 crossrefType "journal-article" @default.
• W2093046114 hasAuthorship W2093046114A5001452107 @default.
• W2093046114 hasAuthorship W2093046114A5026872517 @default.
• W2093046114 hasAuthorship W2093046114A5045867873 @default.
• W2093046114 hasAuthorship W2093046114A5055374370 @default.
• W2093046114 hasAuthorship W2093046114A5066272361 @default.
• W2093046114 hasAuthorship W2093046114A5080984608 @default.
• W2093046114 hasAuthorship W2093046114A5088160011 @default.
• W2093046114 hasConcept C181199279 @default.
• W2093046114 hasConcept C185592680 @default.
• W2093046114 hasConcept C2777477808 @default.
• W2093046114 hasConcept C2780643102 @default.
• W2093046114 hasConcept C2781109383 @default.
• W2093046114 hasConcept C538909803 @default.
• W2093046114 hasConcept C55493867 @default.
• W2093046114 hasConcept C71240020 @default.
• W2093046114 hasConceptScore W2093046114C181199279 @default.
• W2093046114 hasConceptScore W2093046114C185592680 @default.
• W2093046114 hasConceptScore W2093046114C2777477808 @default.
• W2093046114 hasConceptScore W2093046114C2780643102 @default.
• W2093046114 hasConceptScore W2093046114C2781109383 @default.
• W2093046114 hasConceptScore W2093046114C538909803 @default.
• W2093046114 hasConceptScore W2093046114C55493867 @default.
• W2093046114 hasConceptScore W2093046114C71240020 @default.
• W2093046114 hasIssue "2" @default.
• W2093046114 hasLocation W20930461141 @default.
• W2093046114 hasLocation W20930461142 @default.
• W2093046114 hasOpenAccess W2093046114 @default.
• W2093046114 hasPrimaryLocation W20930461141 @default.
• W2093046114 hasRelatedWork W2021331371 @default.
• W2093046114 hasRelatedWork W2033911002 @default.
• W2093046114 hasRelatedWork W2084671922 @default.
• W2093046114 hasRelatedWork W2163536072 @default.
• W2093046114 hasRelatedWork W2315575379 @default.
• W2093046114 hasRelatedWork W2404432230 @default.
• W2093046114 hasRelatedWork W2560223734 @default.
• W2093046114 hasRelatedWork W2949270372 @default.
• W2093046114 hasRelatedWork W2952323845 @default.
• W2093046114 hasRelatedWork W4253727616 @default.
• W2093046114 hasVolume "12" @default.
• W2093046114 isParatext "false" @default.
• W2093046114 isRetracted "false" @default.
• W2093046114 magId "2093046114" @default.
• W2093046114 workType "article" @default.